Victoria, BC – GuideStar Medical Devices (GuideStar) team members Michael Dolphin and Ryan Ruedebusch attended the 2025 AANA Annual Congress in Nashville from August 9-13. The AANA Annual Congress is the largest educational event for CRNAs in the USA, and hosts over 4,000 attendees. GuideStar was happy to demonstrate EpiZact to experienced CRNAs who were interested in adopting EpiZact into their practice, and to CRNA students who were exploring the innovative devices available in their field.

 

The GuideStar team looks forward to conducting clinical evaluations with the contacts made at AANA, including larger rollouts within anesthesia services firms, which have already begun.

​​

About EpiZact
Epidurals are performed to provide anesthesia to a patient, by means of injection of medication into the epidural space. Traditionally, epidurals are performed using the “loss of resistance” technique. EpiZact is the first device developed for epidurals that is designed to stop the forward motion of the needle upon sensing a loss of resistance, providing a tactile and visual signal to the user while simultaneously stopping the needle from further advancement, potentially reducing the incidence of accidental dural puncture.

About GuideStar
GuideStar Medical Devices is a medical device company located in Victoria, BC. The Company’s flagship device, EpiZact, was designed with the intent of reducing the incidence of accidental dural punctures during epidural administration. GuideStar is committed to offering innovative solutions to unmet medical needs with a primary goal of enhancing patient safety.

 

Investor Contact
Mike Dolphin
CEO, GuideStar Medical Devices
info@guidestarmd.com